- Home
- PMTS vs CCCC Comparison
PMTS vs CCCC Comparison
Compare PMTS & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- CCCC
- Stock Information
- Founded
- PMTS 2007
- CCCC 2015
- Country
- PMTS United States
- CCCC United States
- Employees
- PMTS N/A
- CCCC N/A
- Industry
- PMTS Finance Companies
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- CCCC Health Care
- Exchange
- PMTS Nasdaq
- CCCC Nasdaq
- Market Cap
- PMTS 295.6M
- CCCC 405.6M
- IPO Year
- PMTS 2015
- CCCC 2020
- Fundamental
- Price
- PMTS $23.33
- CCCC $6.21
- Analyst Decision
- PMTS Strong Buy
- CCCC Buy
- Analyst Count
- PMTS 3
- CCCC 6
- Target Price
- PMTS $32.00
- CCCC $10.50
- AVG Volume (30 Days)
- PMTS 34.6K
- CCCC 712.7K
- Earning Date
- PMTS 11-05-2024
- CCCC 10-30-2024
- Dividend Yield
- PMTS N/A
- CCCC N/A
- EPS Growth
- PMTS N/A
- CCCC N/A
- EPS
- PMTS 1.52
- CCCC N/A
- Revenue
- PMTS $439,489,000.00
- CCCC $29,378,000.00
- Revenue This Year
- PMTS $7.13
- CCCC $39.70
- Revenue Next Year
- PMTS $5.39
- CCCC N/A
- P/E Ratio
- PMTS $15.18
- CCCC N/A
- Revenue Growth
- PMTS N/A
- CCCC 83.26
- 52 Week Low
- PMTS $12.65
- CCCC $1.06
- 52 Week High
- PMTS $31.00
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- PMTS 37.21
- CCCC 53.88
- Support Level
- PMTS $23.01
- CCCC $6.02
- Resistance Level
- PMTS $24.35
- CCCC $7.14
- Average True Range (ATR)
- PMTS 0.63
- CCCC 0.37
- MACD
- PMTS -0.02
- CCCC 0.10
- Stochastic Oscillator
- PMTS 32.06
- CCCC 57.14
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.